-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
▎Editor of WuXi AppTec content team
Recently, Pacira BioSciences published positive datafrom a Phase 3 clinical trial of its drug EXPAREL as a single-dose popliteal sciatic blocker for postoperative local analgesia in patients undergoing bunion resection.
Image source: 123RF
Papira plans to file a Supplement New Drug Application (sNDA) with the FDA early next year to expand the scope of the EXPAREL label to include sciatic block in the popliteal fossa and femoral nerve block in the adductor tube
.
WuXi AppTec provides integrated, end-to-end new drug development and manufacturing services to the global biopharmaceutical industry, covering the fields
of chemical drug development and production, biological research, preclinical testing and clinical trial development, cell and gene therapy development, testing and production.
If you have relevant business needs, please click on the picture below to fill in the specific information
.